Stivarga (regorafenib) — Medica
Gastrointestinal stromal tumor (GIST)
Initial criteria
- age ≥ 18 years
- EITHER (tried BOTH imatinib or Ayvakit (avapritinib) AND sunitinib or Sprycel (dasatinib)) OR used as first-line therapy for succinate dehydrogenase (SDH)-deficient disease
Approval duration
1 year